MLM Medical Labs
Scott Houlton has a strong and diverse work experience in various roles and companies. Scott is currently the CEO of MLM Medical Labs since February 2021. Prior to this, they served as a board member at Tergus Pharma starting from June 2019. In 2018, they worked as a CEO Advisory Board Member at Great Point Partners. From 2016 to 2020, they were the CEO of CSM, where they successfully acquired and established a new global provider of clinical packaging and logistics. Before that, Scott worked as the President of Development and Clinical Services at Catalent from 2009 to 2016, during which they established and grew a new business unit and led an acquisition. Scott also held leadership positions at Aptuit, Quintiles, Cardinal Health, and General Electric, where they gained valuable experience in diverse areas such as operations, clinical packaging, business development, and financial analysis.
Scott Houlton earned a Bachelor's Degree in Finance and International Business from The Ohio State University between the years 1984 and 1988.
This person is not in any offices
MLM Medical Labs
1 followers
MLM Medical Labs is a leading specialty and central laboratory with comprehensive research services and diagnostic capabilities in Europe and the United States. Offering standard and fully customizable analytical and logistics services across a variety of therapeutic areas, we add value at every stage of the drug development process, from nonclinical and preclinical through phase IV clinical trials. Each therapeutic area is supplemented extensively by different models and batteries of in vitro and ex vivo analyses, offering answers to your therapeutics’ effect on over 900+ parameters while accelerating your research programs. With our strong reputation for scientific expertise, passionate approach to customer care, and adherence to quality data, we empower clients ranging from emerging biotech to Top Ten Global Pharma companies to reach confident clinical decisions that ultimately serve to improve patient lives.